Introduction
Clinical manifestations due to respiratory diseases in childhood are the most frequent reason for medical consultation, resulting in high demand for health services in all levels of care. 1, 2 In the International Study of Wheezing in Infants in Latin America (EISL for its Spanish acronym), 1 the prevalence of infants who had at least one wheezing episode in their first year of life ranged between 22.4% and 58.9%, with wide variability among the different participating centers.
According to data published in the United States, approximately 800,000 infants (20% of the birth cohort) receive outpatient medical intention in the first 12 months of life for viral respiratory infections. 3 The primary agent involved is the respiratory syncytial virus (RSV) that affects 90% of patients younger than 24 months, 4 of which 40% develop bronchiolitis. 5 Obstructive lung disease whose foremost symptom is wheezing remains a frequent problem in pediatrics, especially in the first year of life, since not all patients with recurrent wheezing develop asthma. 6 Recurrent wheezing occurs in a significant proportion of infants and has been associated with respiratory viral infections, mainly with RSV and rhinovirus, among others. 7 On the other hand, the epidemiology of asthma is well known for school-age children, adolescents, and adults. However, the prevalence of recurrent wheezing and associated factors for its development among infants is still under study. Evidence shows an increase in the number of wheezing episodes in infants with a history of viral respiratory infection at an early age. This association has been described even into adulthood in long-term follow-up studies. [8] [9] [10] Therefore, discerning when a wheezing episode is due to a respiratory infection or when it is the beginning of the clinical presentation of asthma at this age is a challenge.
11
In addition to assessing the prevalence of recurrent wheezing in the first year of life in infants in Buenos Aires, the objective of this study was to identify the factors associated with these episodes.
Methods
This work, which is part of the EISL, was an observational, analytical, cross-sectional study using a written, standardized and validated survey (ĸ test: 0.98) 12 aimed at parents of healthy infants aged 12 to 15 months. They went for their checkup and got vaccinated. The questionnaire referred to what happened during the first 12 months of life. This study was conducted from March 2011 to October 2012 at the Consultorio de Niño Sano and the Vaccine Center from the Ricardo Gutiérrez Child Hospital in Buenos Aires (HNRG for its Spanish acronym). 1,063 interviews were conducted. However, for EISL study, we estimated the sample size in each participating center should include at least 984 infants, considering a wheezing prevalence between 25% and 30%, with a power of 80% and a significance level of 0.05.
The questionnaire included 50 questions about what happened in the infants during its first year of life. It included demographic (sex, age, number of siblings, number of cohabitants) and environmental (fuel used for cooking, cohabiting smokers, presence or absence of air conditioning, carpet, pet, cell phone) characteristics. Also, educational (maternal education level) characteristics, breastfeeding and its duration as well as smoking during pregnancy. Family history (mother, father, and siblings) of asthma, rhinitis and allergic dermatitis as well. For infants, respiratory symptoms (age of onset, recurrence of a wheezing episode, colds, pneumonia, presence of a cough, nocturnal wheezing) were considered; medication received (inhaled bronchodilators, systemic corticosteroids, inhaled corticosteroids, antileukotrienes, antibiotics, acetaminophen); medical consultations and hospitalizations because of respiratory symptoms.
Before the survey, the medical concept of wheezing and obstructive bronchitis was explained to the interviewee. In the study, the dependent variable "wheeze episodes" was defined as a positive response from parents to the question "Has your baby had one or more episodes of wheezing in the first year of life?" Moreover, categorized as "occasional" (up to two episodes), or "recurrent" (three or more episodes).
Data were recorded in an Excel spreadsheet and analyzed using the statistical package SPSS 16 version (SPSS, Inc., [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] . For all the variables, the distribution of frequencies and percentages was established concerning the total number of cases. For the measurements in ordinal scale or higher the following data were computed: the number of cases, minimum value, maximum value, arithmetic mean, standard deviation, and any other that would have been applicable from the frequency distribution.
The qualitative data were analyzed statistically using the χ 2 test or the Fisher test and the univariate and multivariate logistic regression analysis. For the level of significance, a p ≤ 0.05 was used.
The Ethics Committee and the Teaching and Research Committee of the HNRG of Buenos Aires approved the study, and the written informed consent was obtained for every case.
Results
At the time of health control or vaccination of their children, 1,147 parents of infants were contacted, of which 92.7% agreed to be interviewed (1, 063) . Each one completed the informed consent in writing, of which 96.6% were mothers, and 3.4% were parents.
When the survey was conducted, the average age of the infants was 13.28 months (standard deviation (SD) 1.28 months). Of the 1,063 infants, 626 (58.9%, confidence interval (CI) 95% 55.9-61.9%) had at least one episode of wheezing in the first year of life. Of the 626 patients who had wheezing, 280 (44.7%, 95% CI 40.8-48.7%) had recurrent wheezing (RW). The mean age of the first wheezing episode (occasional and recurrent) was 4.39 months (SD 2.81 months).
According to the demographic, family and clinical characteristics, the comparative analysis of infants with wheezing episodes and those with non-wheezing episodes in the first year of life is shown in table 1. A univariate analysis followed by multivariate analysis adjusted to the following variables were conducted: family asthma, familial rhinitis, the presence of three or more siblings, current maternal smoking, smoking in a partner, hospitalization due to pneumonia, personal atopic dermatitis).
The factors linked to at least one episode of wheezing (n = 626) were as follows (by multivariate analysis): male sex (p = 0.001) (odds ratio (OR) 1.67, 95% CI 1.24-2.24); six or more colds in the first year of life (p < 0.0001) (OR 4.31, 95% CI 2.79-6.65); age of the first cold < 4 months (p < 0.0001) (OR 2.37, 95% CI 1.74-3.23); pneumonia (p < 0.0001) (OR 16, 95% CI 6.92-37.45); smoking during pregnancy (p = 0.01) (OR 1.97, 95% CI 1.17-3.31) (Fig. 1) .
The comparative analysis of sporadic and recurrent wheezing in the first year of life, according to demographic, family, and clinical characteristics is shown in table 2.
The factors associated with RW (by multivariate analysis) were the following: history of six or more colds in the first year of life (p < 0.0001) (OR 2.92, 95% CI 1.83-4.65); presence of the first episode of wheezing before the fourth month of life (p < 0.0001) (OR 3.06, 95% CI 1.70-5.51) and nocturnal wheezing (p < 0.0001) (OR 3.41, 95% CI 2.47-4.72) (Fig. 2) .
Discussion
In this study, the prevalence of infants who had wheezing episodes once or more times in their first year of life was 58.9%. These results are similar to those reported in Montevideo (54.5%), being the highest in the region compared with other centers participating in the EISL study: Bucaramanga (22.4%), Cuiabá (27.1%) and Uruguaiana (28.4%). 1 The prevalence of infants with RW was 26.3%, similar to that reported by Montevideo (26.4%) and higher than that reported in Uruguaiana (14%), Lima (16.6%) and San Pablo (21.7%). 1 The elevated wheezing prevalence in the first year of life, as well as of RW observed in Buenos Aires, and Montevideo could be due to similar climatic factors, given its geographical proximity.
The severity of episodes among patients with RW in our center was the highest in the region. This severity was determined based on the on-call consultations for bronchial obstruction (91.8%), hospitalization for wheezing (47.9%), medical diagnosis of pneumonia (43.2%) and hospitalization for pneumonia (30.7%).
1 It was also noted that the presence of six or more viral respiratory infections in the first year and less than four months after the initial viral respiratory infection age constituted associated factors to the presence of at least one episode of wheeze and RW, harmonizing with previous studies. [13] [14] [15] [16] [17] [18] [19] [20] Several investigations showed a clear association between viral respiratory infections at an early age and the development of wheezing. [21] [22] [23] [24] [25] Other studies concluded that respiratory viral infections in infants, both mild (common cold) and severe (bronchiolitis), would be a predisposing factor for the OR, odds ratio; 95% CI, 95% confidence interval. *Significant P of the univariate analysis development of allergic sensitization later in childhood and adolescence. 13 In Finland, patients hospitalized for rhinovirus with bronchiolitis had an increased risk of asthma. This relationship was maintained until they were ten years old. 14, 15 In Spain, in a recently published study, viral respiratory infections were evaluated in a cohort of newborns using PCR (polymerase chain reaction). It was detected that the rhinovirus was the agent most frequently involved. The authors showed that infants who required hospitalization for their first viral infection had an increased risk of developing recurrent wheezing, compared to infants whose first viral infection was mild or asymptomatic. 26 Furthermore, Bønnelykke et al. 16 evaluated the association between viral respiratory infections (HRSV, rhinovirus, among others) and bacterial infections in infants, and the development of asthma in childhood. They concluded that the total number of respiratory infections suffered at an early age was a risk factor for developing asthma, regardless of the specific causal agent.
One of the factors associated with the development of at least one episode of wheezing was the male gender, coinciding with previous publications. [27] [28] [29] It has been reported that male infants usually have lower VmaxFRC values (maximum expiratory flow at the functional residual capacity level) in comparison to female infants, 30 which could explain the development of wheezing in male patients in this age group. OR, odds ratio; 95% CI, 95% confidence interval. *Significant P of the univariate analysis **MRI (95% CI) of the variables that remain significant in the multivariate analysis (model adjusted for the following variables: family history of asthma, family history of rhinitis, personal history of atopic dermatitis, first cold before the fourth month, pneumonia, hospitalization due to pneumonia, hospitalization due to bronchial obstructive symptoms)
Patients who underwent at least one episode of wheezing were 16 times more likely to suffer from pneumonia than those without any episode of wheezing. In long-term follow-up studies, it was shown that in children < 2 years of age who had suffered bronchiolitis or pneumonia, the prevalence of wheezing increased even in adulthood. [31] [32] [33] The prevalence of mothers who smoked during pregnancy was 10.9% (95% CI 9.13-12.9%). In the United States, the prevalence ranges from 10% to 20%. 34, 35 This study also showed that smoking during pregnancy is an associated factor with at least one episode of wheezing during the first year of life. Similar findings were reported in Latin America and Europe. 1, 2, 28 In mothers who smoke during pregnancy, and even in those who are exposed to secondhand smoke, there is an alteration in the fetal immune response, with a decrease in helper T lymphocytes (CD4 +) and an increase in allergic risk, favoring obstructive bronchial episodes. [36] [37] [38] [39] These alterations could explain, in part, the results observed. Prenatal exposure to maternal smoking decreases pulmonary compliance even further, reducing elastin in the pulmonary interstitium reducing small airways caliber.
Exposure to tobacco smoke was of 45.5%. However, it was not an associated factor for the development of wheezing. Other authors found that exposure to second-hand smoke increases bronchial hyper reactivity proportionally to the number of cigarettes smoked at home; It has even been shown to increase the incidence of asthma in children and adolescents by at least 20%. 38 Breastfeeding among studied infants was not a protective factor against episodes of wheezing. However, it was a clear protection factor in the EISL throughout Latin America. 1 These differences could be due to the number of patients surveyed.
In this study, infants with RW were 3.4 times more likely to present nocturnal wheezing compared to patients with occasional wheezing. Reports in the latest standard of the Global Initiative for Asthma (GINA), 11 showed that infants with recurrent episodes of wheezing, including sleep, guide the diagnosis of asthma. Also, in a study where children from 6 to 20 months old who suffered from RW and had risk factors for developing asthma (family history of asthma or another finding of atopy in one or both parents) were evaluated, a decrease in lung function Vmax FRC was confirmed. 40 It seems that the key to the development of wheezing is in the immunogenic and environmental interaction, in both the fetal period and the first months of life.
The elevated prevalence of recurrent wheezing and its severity expressed in data from hospitalizations and emergency visits for obstructive bronchial symptoms are a fundamental reason for the economic and work burden of health centers and parents.
One limitation was that in a cross-sectional study it is difficult to recognize without a doubt the predictor of the outcome, which would not occur in a longitudinal cohort study. For this reason, some of the factors identified associated with the presence of both occasional and recurrent wheezing could be prevented if their causality was confirmed in a longitudinal cohort study.
The implementation of public health actions aimed at reducing early viral respiratory infections and avoiding maternal smoking in pregnancy could result in a decrease in the prevalence and severity of wheezing episodes in the first year of life.
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